Alnylam Pharmaceuticals Inc
(BSP:A1LN34)
R$
63.06
+1.32 (+2.14%)
Market Cap: 168.76 Bil
Enterprise Value: 158.31 Bil
PE Ratio: 46.49
PB Ratio: 24.71
GF Score: 66/100 Sorry the transcript is not found. Please try another one.